Komori
Stella Pharma (4888) · RiskFirst stated

Limited operating history and difficulty predicting future performance based on historical results

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Uncertainty regarding future business performance and organizational capabilities due to the Company’s limited operating historyA theme 15 companies write about · 15 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 1 of 7 companies on the "Worse" side.

3 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.
Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「The Company was established in June 2007 and has a short corporate history. Accordingly, it is difficult to forecast its future performance and other matters based on its past results. In addition, the possibility of unforeseen problems for the Company cannot be ruled out, and its organisational ability to respond to such problems represents an unknown risk.」

    Identifies the Company's short history since establishment, the difficulty of forecasting future performance based on past results, and its ability to respond to unanticipated problems as new risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Stella Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.